One study highlighted the CBX3/NRF2/GPX2 axis, showing that CBX3 upregulates NRF2 by inhibiting CUL3 transcription, which in turn enhances GPX2 expression, thereby suppressing ferroptosis and promoting multidrug resistance in CRC cells.121. The gene discussed is GPX2; the disease is colorectal carcinoma.